Maravai LifeSciences Holdings, Inc. Accounts Receivable, Allowance for Credit Loss
Maravai LifeSciences Holdings, Inc. (MRVI) had Accounts Receivable, Allowance for Credit Loss of $800.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-02-26
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $800.00K.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss $1.00M.
- 2025-06-30: Accounts Receivable, Allowance for Credit Loss $800.00K.
- 2025-03-31: Accounts Receivable, Allowance for Credit Loss $800.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2025-12-31 | $800.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.00M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $800.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $800.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.20M 10-K · filed 2026-02-26 |
| 2024-09-30 | $800.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $900.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.00M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.40M 10-K · filed 2025-03-18 |
| 2023-09-30 | $2.20M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.40M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.20M 10-K · filed 2024-02-29 |
| 2021-12-31 | $300.00K 10-K · filed 2023-02-28 |
| 2020-12-31 | $400.00K 10-K · filed 2022-03-01 |